Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
about
Cancer Salivary Biomarkers for Tumours Distant to the Oral CavityEmerging technologies for salivaomics in cancer detectionSaliva in the diagnosis of diseasesOral Biofluid Biomarker Research: Current Status and Emerging FrontiersEmerging platforms using liquid biopsy to detect EGFR mutations in lung cancerIntegrated Magneto-Electrochemical Sensor for Exosome Analysis.Liquid biopsy genotyping in lung cancer: ready for clinical utility?The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB)Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study.Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseasesT Oligo-Primed Polymerase Chain Reaction (TOP-PCR): A Robust Method for the Amplification of Minute DNA Fragments in Body Fluids.Saliva Liquid Biopsy for Point-of-Care Applications.Electrochemical Genosensing of Circulating Biomarkers.Saliva diagnostics - Current views and directions.Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy.Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.Salivary biomarkers in cancer detection.Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.Non-blood circulating tumor DNA detection in cancer.Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva.Electric Field-Induced Disruption and Releasing Viable Content from Extracellular Vesicles.Circulating DNA in EGFR-mutated lung cancer.The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.DNA terminal structure-mediated enzymatic reaction for ultra-sensitive discrimination of single nucleotide variations in circulating cell-free DNA.Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients.The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.Human salivary microRNAs in Cancer.Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
P2860
Q28066265-96D0EF37-A397-4F3D-BD69-B51BFCAC7DFBQ28069566-A55B1C62-A50D-4659-BB27-32FAE03A678FQ28069993-21D20388-C4EA-4B33-B29D-F24F4A72FA08Q28077072-BD8E8002-A7D9-4DD8-8F85-6ACC584FA921Q28082499-20B45E4F-585C-48DC-9B6A-B65374D9847BQ28272483-8E7B0E22-0DBB-4E09-B622-0FB86C06F5EDQ33567037-23BFBB28-DDA9-4E5A-8A75-1C6B6EDEE903Q36095650-1B52447F-0671-4024-BDAF-99972077F8A4Q36430821-9ADD7634-9B7A-4B84-BBB4-EACCCFAF4362Q37060387-543683AC-CF62-4B60-9F85-D23FD3F95127Q37107248-ADE26678-F3E6-474F-B0F9-E166149A8C0EQ37588990-FE11E6AC-6DCF-4D1C-8557-70C22E74430AQ37747010-CD4E2755-8F32-4E36-BD46-FA9983EDEACAQ38728726-227F14FF-3919-4985-A987-204C5D168027Q38788831-D9BF165B-D969-423C-BBC8-8A8B3255223EQ38859701-0061EBDB-9C6E-445C-B6CA-A6CFE2E2CE8DQ38920745-628D4C3E-A5A2-4807-AFD4-CC0790F2F1E4Q39036176-11E8FA4F-7A23-4B12-8CCD-99F89237682EQ41969719-7D2B388F-DB92-4D9A-9564-C97B6557C254Q42253044-9E803554-B227-4388-B366-49810446429FQ45956385-CA771521-1150-46BF-8380-0B53DA6E0022Q46630766-DA97AAFD-4BEC-47BF-94B1-FFFAE639DC10Q46917029-FB150773-D7BE-4777-A73C-F8F9FC59A476Q47115593-B5C21C48-E419-4FCA-84EC-7BFAF8EBF6D9Q47162466-807FCB88-BC60-4FFF-893B-795D5E71ACA4Q47299130-F1B001E4-20A4-4D54-A853-50110E8C69ACQ49502117-91F981FC-D72E-4641-BABC-95D0E7CCECEBQ49720695-1B50B98E-CD62-4B91-8737-A904D9358C85Q49980448-CFA181CD-6C32-477E-A98E-EE03736A716AQ52647687-0A70282A-8667-4E62-B809-3FFE0CA6770EQ52669514-4BD0D59E-BC16-4D78-8887-0C622EBD86F8Q58701272-12F95A94-0411-4AEC-982D-B19257C2CD4E
P2860
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
@ast
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
@en
type
label
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
@ast
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
@en
prefLabel
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
@ast
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.
@en
P2093
P2860
P1476
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer
@en
P2093
Chung-Liang Ho
David Chia
David T W Wong
Gabriel Troche
Maruja E Lira
Ziding Feng
P2860
P304
P356
10.1164/RCCM.201406-1003OC
P407
P577
2014-11-01T00:00:00Z